CRISPR THERAPEUTICS AG (CRSP) Stock Analyst Ratings
NASDAQ:CRSP - CH0334081137 - Common Stock
52.74 USD
-0.24 (-0.45%)
52.5 USD
-0.24 (-0.46%)
ChartMill assigns a Buy % Consensus number of 77% to CRSP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.06. This target is 53.69% above the current price.
CRSP was analyzed by 35 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CRSP.
In the previous month the buy percentage consensus was at a similar level.
CRSP was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-08 | Needham | Reiterate | Buy -> Buy |
| 2025-06-27 | Clear Street | Downgrade | Buy -> Hold |
| 2025-06-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-26 | Needham | Reiterate | Buy -> Buy |
| 2025-05-21 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-20 | Needham | Reiterate | Buy -> Buy |
| 2025-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-02-19 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-02-18 | Citigroup | Maintains | Buy -> Buy |
| 2025-02-14 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-02-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-02-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-13 | Stifel | Maintains | Hold -> Hold |
| 2025-02-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-12 | Needham | Reiterate | Buy -> Buy |